FindTrial
Sign In

Circulating biomarkers and disease activity in systemic sclerosis-associated interstitial lung disease

Circulating biomarkers and disease activity in systemic sclerosis-associated interstitial lung disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20200314001
Enrollment
Unknown
Registered
2020-03-14
Start date
2017-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemic sclerosis&#45

Interventions

Non&#45
ILD and non&#45
scleroderma,Systemic sclerosis with interstitial pneumonia
Diagnostic,Diagnostic
Control,ILD

Sponsors

Faculty of Medicine Siriraj Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of systemic sclerosis-associated with interstitial pneumonia in SSc-ILD group 2. Healthy subject with no interstitial lung disease in control group

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years old 2. Pregnancy 3. Patients who had the following conditions: adenocarcinoma of any organs, bacterial or viral pneumonia, and patients who cannot perform pulmonary function tests

Design outcomes

Primary

MeasureTime frame
the correlation between serum biomarkers and disease severity in SSc-ILD At beginning of the study Serum anti-Scl-70, KL-6, and SP-D—

Secondary

MeasureTime frame
Compare the serum levels of these biomarkers in SSc-ILD patients and control subjects At beginning of the study Serum anti-Scl-70, KL-6, and SP-D—

Countries

Thailand

Contacts

Public ContactSupparerk Disayabutr

Siriraj Hospital, Mahidol University

supparearg@gmail.com66851595929

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026